Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronac Mamtani

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
Cardiology in Review|April 16, 2005
Ayurveda and Yoga in Cardiovascular DiseasesRavinder Mamtani, Ronac Mamtani
Cardiology in Review|April 19, 2005
Ayurveda and yoga in cardiovascular diseasesRavinder Mamtani, Ronac Mamtani
JAMA Pediatrics|December 28, 2016
Antibiotics and Obesity-A Burgeoning or Thinning Argument?Frank I Scott, Ronac Mamtani
Urologic Oncology|August 2, 2025
Assessment of synergistic vs. independent drug activity for enfortumab vedotin and pembrolizumab in untreated advanced urothelial carcinomaRyan D Chow, Ronac Mamtani
Expert Review of Anticancer Therapy|December 21, 2010
Vinflunine in the treatment of advanced bladder cancerRonac Mamtani, David J Vaughn
Clinical Genitourinary Cancer|September 7, 2025
Association Between Early on-Treatment Weight Loss With Enfortumab Vedotin Plus Pembrolizumab and Survival in Advanced Urothelial CarcinomaRyan D Chow, Ronac Mamtani
Pharmacoepidemiology and Drug Safety|March 2, 2021
'Considering the totality of evidence: Combining real-world data with clinical trial results to better inform decision-makingRonac Mamtani, Jennifer Lund, Rebecca A Hubbard
Journal of Biopharmaceutical Statistics|November 10, 2021
Integrating real world data and clinical trial results using survival data reconstruction and marginal moment-balancing weightsKylie Getz, Ronac Mamtani, Rebecca A Hubbard
Urology|October 30, 2012
Granulomatosis and testicular germ cell tumorsNeha Jeurkar, Ronac Mamtani, David J Vaughn
JAMA Oncology|November 13, 2025
Reduced-Dose Enfortumab Vedotin, Treatment Continuity, and Survival in Urothelial CancerRyan D Chow, Ramy Sedhom, Ronac Mamtani
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Cardiology in Review|April 16, 2005
Ayurveda and Yoga in Cardiovascular DiseasesRavinder Mamtani, Ronac Mamtani
Cardiology in Review|April 19, 2005
Ayurveda and yoga in cardiovascular diseasesRavinder Mamtani, Ronac Mamtani
JAMA Pediatrics|December 28, 2016
Antibiotics and Obesity-A Burgeoning or Thinning Argument?Frank I Scott, Ronac Mamtani
Urologic Oncology|August 2, 2025
Assessment of synergistic vs. independent drug activity for enfortumab vedotin and pembrolizumab in untreated advanced urothelial carcinomaRyan D Chow, Ronac Mamtani
Expert Review of Anticancer Therapy|December 21, 2010
Vinflunine in the treatment of advanced bladder cancerRonac Mamtani, David J Vaughn
Clinical Genitourinary Cancer|September 7, 2025
Association Between Early on-Treatment Weight Loss With Enfortumab Vedotin Plus Pembrolizumab and Survival in Advanced Urothelial CarcinomaRyan D Chow, Ronac Mamtani
Pharmacoepidemiology and Drug Safety|March 2, 2021
'Considering the totality of evidence: Combining real-world data with clinical trial results to better inform decision-makingRonac Mamtani, Jennifer Lund, Rebecca A Hubbard
Journal of Biopharmaceutical Statistics|November 10, 2021
Integrating real world data and clinical trial results using survival data reconstruction and marginal moment-balancing weightsKylie Getz, Ronac Mamtani, Rebecca A Hubbard
Urology|October 30, 2012
Granulomatosis and testicular germ cell tumorsNeha Jeurkar, Ronac Mamtani, David J Vaughn
JAMA Oncology|November 13, 2025
Reduced-Dose Enfortumab Vedotin, Treatment Continuity, and Survival in Urothelial CancerRyan D Chow, Ramy Sedhom, Ronac Mamtani
Pageof 20